{"database": "scout", "table": "target_layer1_structure", "rows": [["A0A140T913", 50, 30, null, 84.62, 1, 0, 0, 1, 0, "{\"pdb\": {\"uniprot_id\": \"A0A140T913\", \"pdb_count_total\": 50, \"pdb_count_detailed\": 30, \"entries\": [{\"pdb_id\": \"6O4Y\", \"title\": \"Structure of HLA-A2:01 with peptide MM91\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.58, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2019-03-01T00:00:00.000+00:00\", \"release_date\": \"2020-01-15T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}], \"primary_citation\": {\"title\": \"Anin silico-in vitroPipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.\", \"doi\": null, \"pmid\": null, \"journal\": \"Front Immunol\", \"year\": 2019, \"authors\": [\"Mishto, M.\", \"Mansurkhodzhaev, A.\", \"Ying, G.\", \"Bitra, A.\", \"Cordfunke, R.A.\", \"Henze, S.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6O4Z\", \"title\": \"Structure of HLA-A2:01 with peptide MM92\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.5, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2019-03-01T00:00:00.000+00:00\", \"release_date\": \"2020-01-15T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}, {\"comp_id\": \"SULFATE ION\", \"chem_id\": \"SO4\"}], \"primary_citation\": {\"title\": \"Anin silico-in vitroPipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.\", \"doi\": null, \"pmid\": null, \"journal\": \"Front Immunol\", \"year\": 2019, \"authors\": [\"Mishto, M.\", \"Mansurkhodzhaev, A.\", \"Ying, G.\", \"Bitra, A.\", \"Cordfunke, R.A.\", \"Henze, S.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6O51\", \"title\": \"Structure of HLA-A2:01 with peptide MM90\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.55, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2019-03-01T00:00:00.000+00:00\", \"release_date\": \"2020-01-15T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}], \"primary_citation\": {\"title\": \"Anin silico-in vitroPipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.\", \"doi\": null, \"pmid\": null, \"journal\": \"Front Immunol\", \"year\": 2019, \"authors\": [\"Mishto, M.\", \"Mansurkhodzhaev, A.\", \"Ying, G.\", \"Bitra, A.\", \"Cordfunke, R.A.\", \"Henze, S.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6O53\", \"title\": \"Structure of HLA-A2:01 with peptide MM96\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.4, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2019-03-01T00:00:00.000+00:00\", \"release_date\": \"2020-01-15T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"SULFATE ION\", \"chem_id\": \"SO4\"}, {\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}], \"primary_citation\": {\"title\": \"Anin silico-in vitroPipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.\", \"doi\": null, \"pmid\": null, \"journal\": \"Front Immunol\", \"year\": 2019, \"authors\": [\"Mishto, M.\", \"Mansurkhodzhaev, A.\", \"Ying, G.\", \"Bitra, A.\", \"Cordfunke, R.A.\", \"Henze, S.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6UZ1\", \"title\": \"Noncanonical binding of single-chain A6 TCR variant S3-4 in complex with Tax/HLA-A2\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 3.14, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2019-11-14T00:00:00.000+00:00\", \"release_date\": \"2020-10-28T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"F\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [{\"comp_id\": \"2-(N-MORPHOLINO)-ETHANESULFONIC ACID\", \"chem_id\": \"MES\"}], \"primary_citation\": {\"title\": \"An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.\", \"doi\": null, \"pmid\": null, \"journal\": \"Biochemistry\", \"year\": 2020, \"authors\": [\"Singh, N.K.\", \"Alonso, J.A.\", \"Harris, D.T.\", \"Anderson, S.D.\", \"Ma, J.\", \"Hellman, L.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VM7\", \"title\": \"SILv44 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.41, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-01-27T00:00:00.000+00:00\", \"release_date\": \"2021-01-20T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"3\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner\", \"doi\": null, \"pmid\": null, \"journal\": \"Proc Natl Acad Sci U S A\", \"year\": 2021, \"authors\": [\"Smith, A.R.\", \"Alonso, J.A.\", \"Ayres, C.M.\", \"Singh, N.K.\", \"Hellman, L.M.\", \"Baker, B.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VM8\", \"title\": \"SILv44 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.41, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-01-27T00:00:00.000+00:00\", \"release_date\": \"2020-11-25T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [{\"comp_id\": \"CITRATE ANION\", \"chem_id\": \"FLC\"}], \"primary_citation\": {\"title\": \"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner.\", \"doi\": null, \"pmid\": null, \"journal\": \"Proc Natl Acad Sci U S A\", \"year\": 2021, \"authors\": [\"Smith, A.R.\", \"Alonso, J.A.\", \"Ayres, C.M.\", \"Singh, N.K.\", \"Hellman, L.M.\", \"Baker, B.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VM9\", \"title\": \"T4H2 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.9, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-01-27T00:00:00.000+00:00\", \"release_date\": \"2021-01-20T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner\", \"doi\": null, \"pmid\": null, \"journal\": \"Proc Natl Acad Sci U S A\", \"year\": 2021, \"authors\": [\"Smith, A.R.\", \"Alonso, J.A.\", \"Ayres, C.M.\", \"Singh, N.K.\", \"Hellman, L.M.\", \"Baker, B.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VMA\", \"title\": \"T4H2 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.75, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-01-27T00:00:00.000+00:00\", \"release_date\": \"2021-01-20T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner\", \"doi\": null, \"pmid\": null, \"journal\": \"Proc Natl Acad Sci U S A\", \"year\": 2021, \"authors\": [\"Smith, A.R.\", \"Alonso, J.A.\", \"Ayres, C.M.\", \"Singh, N.K.\", \"Hellman, L.M.\", \"Baker, B.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VMC\", \"title\": \"T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.85, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-01-27T00:00:00.000+00:00\", \"release_date\": \"2021-01-20T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"3\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner\", \"doi\": null, \"pmid\": null, \"journal\": \"Proc Natl Acad Sci U S A\", \"year\": 2021, \"authors\": [\"Smith, A.R.\", \"Alonso, J.A.\", \"Ayres, C.M.\", \"Singh, N.K.\", \"Hellman, L.M.\", \"Baker, B.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VQO\", \"title\": \"T cell receptor-p53-HLA-A2 complex\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 3.0, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-02-05T00:00:00.000+00:00\", \"release_date\": \"2020-06-17T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"F\"], \"description\": \"MHC class I antigen\", \"length\": 293}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2020, \"authors\": [\"Wu, D.\", \"Gallagher, D.T.\", \"Gowthaman, R.\", \"Pierce, B.G.\", \"Mariuzza, R.A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VR1\", \"title\": \"Complex of HLA-A2, a class I MHC, with a p53 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.37, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-02-06T00:00:00.000+00:00\", \"release_date\": \"2020-06-10T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen\", \"length\": 293}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2020, \"authors\": [\"Wu, D.\", \"Gallagher, D.T.\", \"Gowthaman, R.\", \"Pierce, B.G.\", \"Mariuzza, R.A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VR5\", \"title\": \"Complex of HLA-A2, a class I MHC, with a p53 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.38, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-02-06T00:00:00.000+00:00\", \"release_date\": \"2020-06-17T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen\", \"length\": 293}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2020, \"authors\": [\"Wu, D.\", \"Gallagher, D.T.\", \"Gowthaman, R.\", \"Pierce, B.G.\", \"Mariuzza, R.A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VRM\", \"title\": \"T cell receptor-p53-HLA-A2 complex\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.61, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-02-08T00:00:00.000+00:00\", \"release_date\": \"2020-06-17T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 293}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2020, \"authors\": [\"Wu, D.\", \"Gallagher, D.T.\", \"Gowthaman, R.\", \"Pierce, B.G.\", \"Mariuzza, R.A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6VRN\", \"title\": \"T cell receptor-p53-HLA-A2 complex\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.46, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-02-08T00:00:00.000+00:00\", \"release_date\": \"2020-06-17T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 293}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2020, \"authors\": [\"Wu, D.\", \"Gallagher, D.T.\", \"Gowthaman, R.\", \"Pierce, B.G.\", \"Mariuzza, R.A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6W51\", \"title\": \"Structure of the antibody fragment H2 in complex with HLA-A*02:01/p53R175H\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 3.53, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-03-12T00:00:00.000+00:00\", \"release_date\": \"2021-03-17T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\", \"G\", \"J\"], \"description\": \"MHC class I antigen\", \"length\": 296}], \"ligands\": [{\"comp_id\": \"PHOSPHATE ION\", \"chem_id\": \"PO4\"}], \"primary_citation\": {\"title\": \"Targeting a neoantigen derived from a common TP53 mutation.\", \"doi\": null, \"pmid\": null, \"journal\": \"Science\", \"year\": 2021, \"authors\": [\"Hsiue, E.H.\", \"Wright, K.M.\", \"Douglass, J.\", \"Hwang, M.S.\", \"Mog, B.J.\", \"Pearlman, A.H.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6Z9V\", \"title\": \"Human Class I Major Histocompatibility Complex, A02 allele, presenting IIGWMWIPV\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.01, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-06-04T00:00:00.000+00:00\", \"release_date\": \"2021-06-30T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen\", \"length\": 276}], \"ligands\": [{\"comp_id\": \"1,2-ETHANEDIOL\", \"chem_id\": \"EDO\"}, {\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"SULFATE ION\", \"chem_id\": \"SO4\"}, {\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}, {\"comp_id\": \"1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE\", \"chem_id\": \"P4G\"}, {\"comp_id\": \"3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL\", \"chem_id\": \"PE8\"}, {\"comp_id\": \"CALCIUM ION\", \"chem_id\": \"CA\"}], \"primary_citation\": {\"title\": \"Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.\", \"doi\": null, \"pmid\": null, \"journal\": \"J Immunol\", \"year\": 2021, \"authors\": [\"Man, S.\", \"Redman, J.E.\", \"Cross, D.L.\", \"Cole, D.K.\", \"Can, I.\", \"Davies, B.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6Z9W\", \"title\": \"Human Class I Major Histocompatibility Complex, A02 allele, presenting LLGWVFAQV\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.7, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-06-04T00:00:00.000+00:00\", \"release_date\": \"2021-06-30T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen\", \"length\": 275}], \"ligands\": [], \"primary_citation\": {\"title\": \"Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.\", \"doi\": null, \"pmid\": null, \"journal\": \"J Immunol\", \"year\": 2021, \"authors\": [\"Man, S.\", \"Redman, J.E.\", \"Cross, D.L.\", \"Cole, D.K.\", \"Can, I.\", \"Davies, B.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"6Z9X\", \"title\": \"Human Class I Major Histocompatibility Complex, A02 allele, presenting LLS (t-butyl)Y FGTPT\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.68, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-06-04T00:00:00.000+00:00\", \"release_date\": \"2021-06-30T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen\", \"length\": 276}], \"ligands\": [{\"comp_id\": \"SULFATE ION\", \"chem_id\": \"SO4\"}], \"primary_citation\": {\"title\": \"Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.\", \"doi\": null, \"pmid\": null, \"journal\": \"J Immunol\", \"year\": 2021, \"authors\": [\"Man, S.\", \"Redman, J.E.\", \"Cross, D.L.\", \"Cole, D.K.\", \"Can, I.\", \"Davies, B.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7BBG\", \"title\": \"CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.64, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2020-12-17T00:00:00.000+00:00\", \"release_date\": \"2021-10-27T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 309}], \"ligands\": [{\"comp_id\": \"SODIUM ION\", \"chem_id\": \"NA\"}], \"primary_citation\": {\"title\": \"Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.\", \"doi\": null, \"pmid\": null, \"journal\": \"Blood\", \"year\": 2021, \"authors\": [\"Augsberger, C.\", \"Hanel, G.\", \"Xu, W.\", \"Pulko, V.\", \"Hanisch, L.J.\", \"Augustin, A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7LG2\", \"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope ALWEIQQVV\", \"keywords\": \"IMMUNE SYSTEM/VIRAL PROTEIN\", \"resolution\": 2.4, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-01-19T00:00:00.000+00:00\", \"release_date\": \"2021-02-03T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}, {\"comp_id\": \"TRIETHYLENE GLYCOL\", \"chem_id\": \"PGE\"}], \"primary_citation\": {\"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope ALWEIQQVV\", \"doi\": null, \"pmid\": null, \"journal\": \"To be published\", \"year\": null, \"authors\": [\"Patskovska, L.\", \"Patskovsky, Y.\", \"Krogsgaard, M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7LG3\", \"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope KLWAQCVQL\", \"keywords\": \"IMMUNE SYSTEM/VIRAL PROTEIN\", \"resolution\": 2.3, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-01-19T00:00:00.000+00:00\", \"release_date\": \"2021-02-03T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope KLWAQCVQL\", \"doi\": null, \"pmid\": null, \"journal\": \"To be published\", \"year\": null, \"authors\": [\"Patskovska, L.\", \"Patskovsky, Y.\", \"Krogsgaard, M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7M8S\", \"title\": \"Crystal Structure of HLA-A*02:01 in complex with KLNDLCFTNV, an 10-mer epitope from SARS-CoV-2 Spike (S386-395)\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.35, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-03-30T00:00:00.000+00:00\", \"release_date\": \"2021-06-23T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"HLA class I histocompatibility antigen, A alpha chain\", \"length\": 276}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules\", \"doi\": null, \"pmid\": null, \"journal\": \"Biophysica\", \"year\": 2021, \"authors\": [\"Nguyen, A.T.\", \"Szeto, C.\", \"Jayasinghe, D.\", \"Lobos, C.A.\", \"Halim, H.\", \"Chatzileontiadou, D.S.M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7MJ6\", \"title\": \"HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.95, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-04-19T00:00:00.000+00:00\", \"release_date\": \"2021-08-18T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 277}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nature\", \"year\": 2021, \"authors\": [\"Yarmarkovich, M.\", \"Marshall, Q.F.\", \"Warrington, J.M.\", \"Premaratne, R.\", \"Farrel, A.\", \"Groff, D.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7MJ7\", \"title\": \"HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.6, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-04-19T00:00:00.000+00:00\", \"release_date\": \"2021-08-18T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 277}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nature\", \"year\": 2021, \"authors\": [\"Yarmarkovich, M.\", \"Marshall, Q.F.\", \"Warrington, J.M.\", \"Premaratne, R.\", \"Farrel, A.\", \"Groff, D.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7MJ8\", \"title\": \"HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.79, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-04-19T00:00:00.000+00:00\", \"release_date\": \"2021-08-18T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 277}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nature\", \"year\": 2021, \"authors\": [\"Yarmarkovich, M.\", \"Marshall, Q.F.\", \"Warrington, J.M.\", \"Premaratne, R.\", \"Farrel, A.\", \"Groff, D.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7MJ9\", \"title\": \"HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 1.75, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-04-19T00:00:00.000+00:00\", \"release_date\": \"2021-08-18T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 277}], \"ligands\": [], \"primary_citation\": {\"title\": \"Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nature\", \"year\": 2021, \"authors\": [\"Yarmarkovich, M.\", \"Marshall, Q.F.\", \"Warrington, J.M.\", \"Premaratne, R.\", \"Farrel, A.\", \"Groff, D.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7MKB\", \"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL\", \"keywords\": \"IMMUNE SYSTEM/VIRAL PROTEIN\", \"resolution\": 1.9, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-04-22T00:00:00.000+00:00\", \"release_date\": \"2021-05-26T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\"], \"description\": \"MHC class I antigen\", \"length\": 274}], \"ligands\": [{\"comp_id\": \"GLYCEROL\", \"chem_id\": \"GOL\"}], \"primary_citation\": {\"title\": \"Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL\", \"doi\": null, \"pmid\": null, \"journal\": \"To be published\", \"year\": null, \"authors\": [\"Nyovanie, S.T.\", \"Patskovsky, Y.\", \"Krogsgaard, M.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7N1A\", \"title\": \"SARS-CoV-2 YLQ peptide binds to HLA-A2\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.065, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-05-27T00:00:00.000+00:00\", \"release_date\": \"2021-07-28T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 276}], \"ligands\": [{\"comp_id\": \"TETRAETHYLENE GLYCOL\", \"chem_id\": \"PG4\"}], \"primary_citation\": {\"title\": \"Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2022, \"authors\": [\"Wu, D.\", \"Kolesnikov, A.\", \"Yin, R.\", \"Guest, J.D.\", \"Gowthaman, R.\", \"Shmelev, A.\"]}, \"related_emdb\": []}, {\"pdb_id\": \"7N1B\", \"title\": \"SARS-CoV-2 RLQ peptide binds to HLA-A2\", \"keywords\": \"IMMUNE SYSTEM\", \"resolution\": 2.81, \"method\": \"X-RAY DIFFRACTION\", \"deposit_date\": \"2021-05-27T00:00:00.000+00:00\", \"release_date\": \"2021-07-28T00:00:00.000+00:00\", \"my_uniprot_chains\": [{\"entity_id\": \"1\", \"chains\": [\"A\", \"D\"], \"description\": \"MHC class I antigen, A-2 alpha chain\", \"length\": 275}], \"ligands\": [], \"primary_citation\": {\"title\": \"Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.\", \"doi\": null, \"pmid\": null, \"journal\": \"Nat Commun\", \"year\": 2022, \"authors\": [\"Wu, D.\", \"Kolesnikov, A.\", \"Yin, R.\", \"Guest, J.D.\", \"Gowthaman, R.\", \"Shmelev, A.\"]}, \"related_emdb\": []}]}, \"alphafold\": {\"uniprot_id\": \"A0A140T913\", \"model_count\": 1, \"models\": [{\"entryId\": \"AF-A0A140T913-F1\", \"uniprotAccession\": \"A0A140T913\", \"uniprotDescription\": \"Major histocompatibility complex, class I, A\", \"organismScientificName\": \"Homo sapiens\", \"sequenceLength\": null, \"globalMetricValue\": 84.62, \"modelCreatedDate\": \"2022-06-01T00:00:00Z\", \"latestVersion\": 6, \"cifUrl\": \"https://alphafold.ebi.ac.uk/files/AF-A0A140T913-F1-model_v6.cif\", \"pdbUrl\": \"https://alphafold.ebi.ac.uk/files/AF-A0A140T913-F1-model_v6.pdb\", \"paeImageUrl\": \"https://alphafold.ebi.ac.uk/files/AF-A0A140T913-F1-predicted_aligned_error_v6.png\"}]}, \"emdb\": {\"uniprot_id\": \"A0A140T913\", \"emdb_count\": 0, \"entries\": []}}", "2026-05-27T10:45:01.805491+00:00"]], "columns": ["target_id", "pdb_count_total", "pdb_count_detailed", "pdb_best_resolution_A", "alphafold_mean_pLDDT", "alphafold_model_count", "emdb_count", "has_cryoEM", "has_xray", "has_NMR", "raw_json", "recorded_utc"], "primary_keys": ["target_id"], "primary_key_values": ["A0A140T913"], "units": {}, "query_ms": 0.39903099968796596, "source": "apt-scout automated curation pipeline (E. Dohi, NCNP) \u2014 values harvested from public databases; raw source stored per target", "source_url": "https://apt-scout.org", "license": "CC BY 4.0", "license_url": "https://creativecommons.org/licenses/by/4.0/"}